Active Surveillance Feasible for Low-Risk Thyroid Cancer
THURSDAY, Sept. 22, 2022 -- Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 in JAMA Oncology.
Allen S. Ho, M.D., from Cedars-Sinai Medical Center in Los Angeles, and...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news